We typically sell innovative ingredients to product manufacturers, in the consumer care, agrochemical, or pharmaceutical sectors. Our ingredients provide vital functionality at low inclusion levels, ensuring efficacy or helping to differentiate customers’ products, with consumers benefitting through the application of those products.
Committed to sustainability
We are committed to becoming the most sustainable supplier of innovative ingredients. We will develop and supply solutions to tackle some of the biggest challenges the world is facing and by 2030 we will be Climate, Land and People Positive.
Our customers use our ingredients to differentiate their own products and to meet sustainability commitments, regulatory requirements and changing consumer demands. Climate change, biodiversity loss, widening inequalities, changing demographics, overexploitation of resources and innovation in digital technologies are transforming consumer demands. Through our customers and their products, our ingredients can improve consumers lives by minimising the negative impacts of consumption and help make positive impacts on planet and society.
;
Delivering positive impact
The breadth of our portfolio of sustainable ingredients and sector-leading Sustainability Commitment help us to have a positive impact on everyday life by...
Employee Value Proposition
Meeting global challenges
Of the trends affecting our markets and supply chains, we have identified three global challenges that our strategy helps to address.
Feeding a growing population and restoring nature
Feeding a global population that is expected to reach 10 billion people by 2055 will require a 70% increase in agricultural output1. With most suitable land already farmed, increased output will come from higher yields and growing more resilient crops on less suitable land, supported by restoring degraded ecosystems and nature.
Living more sustainably within planetary boundaries
Population growth and increasing consumption, fuelled by the expansion of the middle class particularly in developing countries, are putting pressure on planetary systems such as water, climate and biodiversity, and scarce natural resources. Addressing this challenge requires transformational new approaches to consumption and circularity.
Global demand
for health and wellbeing
The pandemic has made consumers more conscious of their physical and mental wellbeing, and expanded demands on healthcare systems, already increasing due to a growing and ageing population. This has increased demand for effective ingredients that are underpinned by science and support physical and mental health.
Continued strategic investment
Well positioned for recovery
Completed the acquisition of Solus Biotech adding naturally-derived ceramides and phospholipids to the portfolio.
Prioritising investment in Consumer Care in Asia, with new R&D labs in Shanghai and a manufacturing site in India to be commissioned in 2025.
Scaling up Pharma to support ongoing expansion of customer drug pipelines, with a new R&D lab in India and additional nucleic acid delivery capacity expected on-stream in 2025.
;